Success Factors for the Smoking Cessation Service of the Safe Pharmacy

Kang, Eunjeong; Park, Hyekyung

doi:10.24304/kjcp.2017.27.1.38

Cited by 2 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SAFE pharmacies have the purpose of making patients safe and healthy by managing their medical history, preventing suicide, and promoting smoking cessation. 16 , 17 The activities of the SMART pharmacy in Busan focus on providing “S”afe drug information, “M”anagement of personal health care, “A”ccurate disease information, “R”eliable, trustworthy pharmacy, “T”eaching for prevention and management of cardiovascular diseases, but no clinical outcomes have been published yet. 18…”

Section: Introductionmentioning

confidence: 99%

Satisfaction and expressed needs of pharmaceutical care services and challenges recognized by patients in South Korea

Kang¹,

Rhew²,

Oh³

et al. 2017

PPA

View full text Add to dashboard Cite

PurposeTo assess the degree of satisfaction and expressed needs of pharmaceutical care services in patients with chronic diseases and explore the factors related to the needs from patients’ perspectives for the further development of pharmaceutical care service models.Patients and methodsA cross-sectional survey of 220 patients (mean age ± SD: 61.3±13.1, male:female: 104:116) was conducted. The questionnaire was structured to measure patients’ degree of satisfaction and expressed needs using a 5-point Likert scale. Additionally, preferred duration, methods of service delivery, and willingness to pay were surveyed. Responses were analyzed using an ordinal regression method to predict factors that were related to pharmaceutical care services.ResultsSixty-seven patients had experienced pharmaceutical care services. Their satisfaction levels were high in all categories; however, there were no significant differences between categories. The levels of expressed needs were similar among categories without significant differences. The preferred delivery method was a face-to-face conversation combined with being provided with written information (53.2%). The preferred duration was ≤10 min (70.5%). About 48% of the patients showed willingness to pay for the service. Education level and region influenced patients’ needs.ConclusionThe satisfaction and needs of pharmaceutical care services was very positive; however, noticing only a third of patients experienced pharmaceutical care services, this may indicate a lack of awareness and less appreciation of pharmacists by patients. Details concerning patients’ awareness and the value of pharmaceutical care services require further investigation.

show abstract

Section: Introductionmentioning

confidence: 99%

Satisfaction and expressed needs of pharmaceutical care services and challenges recognized by patients in South Korea

Kang¹,

Rhew²,

Oh³

et al. 2017

PPA

View full text Add to dashboard Cite

show abstract

Cost-Effectiveness Analysis of Smoking Cessation Interventions With Behavioral Support: A Study Based on the Benefits of Smoking Cessation on Outcomes (BENESCO) Model

Park

Kang

Lee

2022

Nicotine &Amp; Tobacco Research

View full text Add to dashboard Cite

Introduction Few studies have compared cost-effectiveness between different smoking cessation interventions (SCIs) that include behavioral support, considering smoking-related diseases. Therefore, we compare the cost-effectiveness between SCIs with behavioral support in South Korea using the Benefits of Smoking Cessation on Outcomes (BENESCO) model. Methods We used the BENESCO model to estimate the cost and utility of the SCIs with behavioral support, including pharmacist counseling with nicotine replacement therapy (pharmacist+NRT), expert counseling with NRT (expert+NRT), and expert counseling with varenicline (expert+varenicline). The target population was adult smokers who wanted to cease smoking within 1 month. We applied transitional probabilities and epidemiological data from the literature. Medical costs and utilities were calculated using claims and national survey data, respectively. Cost-effectiveness was evaluated within the threshold (17,926 USD per quality-adjusted life years [QALYs]) by incremental cost-effectiveness ratio (ICER). Results The model cohort included 1,219,390 male and 298,511 female smokers. The pharmacist+NRT group had 32,842 more QALYs gained and 26,689,958 USD less expended than the expert+NRT group. The ICER for the expert+varenicline group versus the pharmacist+NRT and expert+NRT groups was 27,247 and 4,074 USD per QALY, respectively. The robustness of the results was confirmed by sensitivity analyses, except for the discount rate and cost of the expert+varenicline group. Conclusions In Korea, pharmacist counseling with NRT showed higher QALY gains and lower costs than expert counseling with NRT. Expert counseling with varenicline was more effective for smoking cessation and more cost-effective than expert counseling with NRT but was not cost-effective compared to pharmacist counseling with NRT. Implications This study provides evidence for decision-making on smoking cessation programs by evaluating the cost-effectiveness of SCIs. Furthermore, we attempted to use the BENESCO model to compare and evaluate the cost-effectiveness of SCIs with behavioral support. It is meaningful because this study showed the availability of using the BENESCO model in the future cost-effectiveness analysis of various SCIs.

show abstract

Success Factors for the Smoking Cessation Service of the Safe Pharmacy

Cited by 2 publications

References 13 publications

Satisfaction and expressed needs of pharmaceutical care services and challenges recognized by patients in South Korea

Satisfaction and expressed needs of pharmaceutical care services and challenges recognized by patients in South Korea

Cost-Effectiveness Analysis of Smoking Cessation Interventions With Behavioral Support: A Study Based on the Benefits of Smoking Cessation on Outcomes (BENESCO) Model

Contact Info

Product

Resources

About